Trending Topics

3 minutes ago

Why Strong Science Isn't Enough

Breaking News

  • 2 hours ago

  • Pharma Now Editorial Team

Bayer Acquires Perfuse Therapeutics in $2.45 Billion Deal for Ocular Pipeline Asset PER-001
Breaking News

More News

Safic-Alcan Acquires Majority Stake in SA Ingredients to Deepen India Pharma Supply Reach

Safic-Alcan Acquires Majority Stake in SA Ingredients to Deepen India ...

Pharma Now Editorial Team

Ad
Advertisement

Interviews & Opinions

Article

A gold medalist who swept floors, rejected an IIT-equivalent seat, and reached Technical Director at GSK by 34 — Mr. Shyam Khante's five leadership pi...

FT - Mr. Shyam Khante

Read More

Article
“Quality is Driven by Science” – Leadership Lessons from Zydus President Vikram Shukla

FT - Mr. Vikram Shukla

Ad
Advertisement

For the Leaders

leadership

The LIMS Decision: Why Your Laboratory Software Choice Is Now a Regulatory and Strategic Imperative

Ravindra Warang | Apr 18, 2026

For Leaders

eQMS Migration in Pharma: The Step-by-Step Guide for Leaders

Mrudula Kulkarni | Apr 14, 2026

For Leaders

How India Is Rebuilding Its Pharmaceutical Innovation Engine

Dr. Ranjan Chakrabarti, Ph.D. | Jan 26, 2026

For Leaders

From Compliance to Connection: Storytelling As A Leadership Tool In Pharma

Simantini Singh Deo | Nov 18, 2025

Value-Based Marketing & Outcome-Oriented Messaging In The Pharma Industry

Value-Based Marketing & Outcome-Oriented Messaging In The Pharma Industry

Simantini Singh Deo | Mar 17, 2026

AI in Pharma

ai-pharma

Article

Key Takeaways from Pharma Now’s Webinar on AI in GxP with Dr. Ajaz Hussain

Watch the biggest takeaways from Pharma Now’s webinar on AI in GxP with Dr. Ajaz Hussain and what pharma IT leaders must do next.

by Pharma Now Editorial Team


07-05-2026

THE NEW EPISTEMIC CONTRACT FOR ARTIFICIAL INTELLIGENCE IN GXP ENVIRONMENT: Stepping Beyond Compliance Theatre

Dr. Ajaz Hussain

Ad

Pharma Shorts